BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 11464497)

  • 1. [Adjuvant chemotherapy in gastric carcinoma].
    Degiuli M; Ortega C; Mineccia M
    Ann Ital Chir; 2001; 72(1):55-8. PubMed ID: 11464497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complementary treatment to surgery of gastric carcinoma: role of adjuvant and neoadjuvant chemotherapy].
    Lise M; Nitti D; Marchet A; Tripodi M; Pilati P; Pasetto L
    Chir Ital; 1997; 49(3):35-9. PubMed ID: 9612650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Predictive value of orotate phosphoribosyltransferase in chemoresistant patients with gastric carcinoma who underwent S-1-based neoadjuvant/adjuvant chemotherapy].
    Sakurai Y; Kamoshida S; Furuta S; Sunagawa R; Inaba K; Isogaki J; Komori Y; Uyama I; Tsutsumi Y
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1147-55. PubMed ID: 18633253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute.
    Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC
    Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of adjuvant chemoradiotherapy in the treatment of gastric carcinoma].
    Kocáková I; Vetchá H; Soumarová R; Vyzula R
    Cas Lek Cesk; 2003; 142 Suppl 1():26-8. PubMed ID: 12924046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
    Sun P; Xiang JB; Chen ZY
    Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group.
    Van Cutsem E; Van de Velde C; Roth A; Lordick F; Köhne CH; Cascinu S; Aapro M;
    Eur J Cancer; 2008 Jan; 44(2):182-94. PubMed ID: 18093827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators in locally advanced gastric cancer (LAGC) treated with preoperative chemotherapy and D2-gastrectomy.
    Persiani R; D'Ugo D; Rausei S; Sermoneta D; Barone C; Pozzo C; Ricci R; La Torre G; Picciocchi A
    J Surg Oncol; 2005 Mar; 89(4):227-36; discussion 237-8. PubMed ID: 15726615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
    Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
    World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
    Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
    Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of immunochemo-surgery for gastric carcinoma.
    Kim JP; Yu HJ; Lee JH
    Hepatogastroenterology; 2001; 48(41):1227-30. PubMed ID: 11677936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].
    Káposztás Z; Cseke L; Kalmár K; Horváth OP
    Magy Seb; 2002 Oct; 55(5):321-4. PubMed ID: 12474518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.
    Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK
    Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gastrojejunostomy for irresectable gastric cancer with pyloric stenosis-new role of surgery in the era of S-1].
    Matsumoto T; Fujiwara Y; Yamamoto N; Hayashi C; Koishi K; Kojima S; Tanaka J; Kobayashi M; Yamamura T; Miwa H; Tomita N; Sasako M
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):641-5. PubMed ID: 19381039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of adjuvant chemotherapy in the long-term outcome of patients with resected gastric cancer.
    Grau JJ; Martín M; Fuster J; Pera M; García-Valdecasas JC; Bombí JA; Bordas JM; Alcobendas F; Grande L; Estapé J
    J Surg Oncol; 2003 Apr; 82(4):234-40. PubMed ID: 12672007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy (ECF regimen) for patients with gastric adenocarcinoma.
    Saletti P; Berthold D; Ghielmini M; Zucca E; Fazio N; Goldhirsch A; Cavalli F
    Hepatogastroenterology; 2007; 54(75):969-72. PubMed ID: 17591105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postoperative radio-chemotherapy in locally advanced gastric cancer].
    Garrido M; Bustos M; Orellana E; Madrid J; Galindo H; Sánchez C; Pimentel F; Guzmán S; Ibáñez L; Butte JM; Alvarez M; Besa P
    Rev Med Chil; 2008 Jul; 136(7):844-50. PubMed ID: 18949159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.